Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Virax Biolabs Group Limited (VRAX)

Virax Biolabs Group Limited (VRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Virax Biolabs Group Limited BioCity Glasgow Bo Ness Road Newhouse Lanarkshire X0 ML1 5UH GBR

www.viraxbiolabs.com Employees: 19 P: 44-0-20-7788-7414

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Virax Biolabs Group Limited is a biotechnology company focused on the prevention, detection, and diagnosis of viral diseases as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus. Virax Biolabs Group Limited is based in London, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 860
Enterprise Value, $K -3,340
Shares Outstanding, K 4,342
Float, K 2,384
% Float 54.90%
Short Interest, K 11
Short Float 0.24%
Days to Cover 1.00
Short Volume Ratio 0.23
% of Insider Shareholders 45.10%
% of Institutional Shareholders 8.61%

Financials:

Annual Sales, $ 10 K
Annual Net Income, $ -6,060 K
EBIT, $ 0 K
EBITDA, $ -5,820 K

Growth:

1-Year Return -84.74%
3-Year Return -97.37%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 07/01/26
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/18/23

VRAX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -60,600.00%
Debt/Equity 0.04
Price/Sales 260.23
Price/Cash Flow N/A
Price/Book 0.19
Book Value/Share 1.17
Interest Coverage -102.33
60-Month Beta 1.61
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.